Icatibant
Specifications
130308-48-4CAS Number
(2S)-2-[[(2S,3aS,7aS)-1-[(3R)-2-[(2S)-2-[[(2S)-2-[[2-[[(2S,4R)-1-[(2S)-1-[(2S)-2-[[(2R)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]-4-hydroxypyrrolidine-2-carbonyl]amino]acetyl]amino]-3-IUPAC Name
C59H89N19O13SChemical Formula
1304.5 g/molMolecular Weight
Icatibant; 130308-48-4; icatibanto; HOE140; 7PG89G35Q7; DTXSID20903963; L-Arginine, D-arginyl-L-arginyl-L-prolyl-trans-4-hydroxy-L-prolylglycyl-3-(2-thienyl)-L-alanyl-L-seryl-D-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-L-(2alpha,3abeta,7abeta)-octahydro-1H-indole-2-carbonyl-; JE-049; icatibantum; RefChem:57034; B06AC02; DTXCID901331902; (N-(N-(D-arginyl-DL-arginyl-DL-prolyl-(4R)-4-hydroxy-DL-prolyl-glycyl-3-(2-thienyl)-L-alanyl-L-seryl)-1,2,3,4-tetrahydroisoquinoline-3-carbonyl)-(3aS,7aS)-octahydroindole-2-carbonyl)-L-arginine; D-Arg(Hyp(3)-Thi(5)-D-Tic(7)-Oic(8))BK; D-Arg(Hyp(3)-Thi(5)-L-Tic(7)-Oic(8))BK; (2S)-2-(((2S,3aS,7aS)-1-((3R)-2-((2S)-2-(((2S)-2-((2-(((2S,4R)-1-((2S)-1-((2S)-2-(((2R)-2-amino-5-(diaminomethylideneamino)pentanoyl)amino)-5-(diaminomethylideneamino)pentanoyl)pyrrolidine-2-carbonyl)-4-hydroxypyrrolidine-2-carbonyl)amino)acetyl)amino)-3-thiophen-2-ylpropanoyl)amino)-3-hydroxypropanoyl)-3,4-dihydro-1H-isoquinoline-3-carbonyl)-2,3,3a,4,5,6,7,7a-octahydroindole-2-carbonyl)amino)-5-(diaminomethylideneamino)pentanoic acid; CHEBI:68556; Firazyr; C59H89N19O13S; Icatibant [INN]; ((2S,3aS,7aS)-1-((R)-2-(((S)-2-(2-((2S,4R)-1-(D-Arginyl-L-arginyl-L-prolyl)-4-hydroxypyrrolidine-2-carboxamido)acetamido)-3-(thiophen-2-yl)propanoyl)-L-seryl)-1,2,3,4-tetrahydroisoquinoline-3-carbonyl)octahydro-1H-indole-2-carbonyl)-L-arginine; Icatibant [INN:BAN]; UNII-7PG89G35Q7; icatibant-acetate; JE 049; Icatibant (Standard); Icatibant HOE 140; ICATIBANT [MI]; ICATIBANT [VANDF]; HOE-140 (Icatibant); ICATIBANT [WHO-DD]; ICATIBANT [EMA EPAR]; HOE 140 TFA; CHEMBL2028850; SCHEMBL21495177; SCHEMBL21495179; GLXC-22881; BDBM50403371; BDBM50406750; EBC-27548; HY-17446R; AKOS040741862; AT24149; CS-3381; DB06196; FI45882; NCGC00390805-02; DA-64221; HY-17446; HOE 140, >=94%; D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-Tic-Oic-Arg; EN300-18166877; Q902379; BRD-K63772874-001-01-4; BRD-K63772874-001-02-2; (R)-ARGINYL-(S)-ARGINYL-(S)-PROLYL-(2S,4R)-(4-HYDROXYPROLYL)GLYCYL-(S)-(3-(2-THIENYL)ALANYL)-(S)-SERYL-(R)-((1,2,3,4-TETRAHYDRO-3-ISOQUINOLYL)CARBONYL)-(2S,3AS,7AS)-((HEXAHYDRO-2-INDOLINYL)CARBONYL)-(S)-ARGININE; L-ARGININE, D-ARGINYL-L-ARGINYL-L-PROLYL-TRANS-4-HYDROXY-L-PROLYLGLYCYL-3-(2-THIENYL)-L-ALANYL-L-SERYL-D-1,2,3,4-TETRAHYDRO-3-ISOQUINOLINECARBONYL-L-(2.ALPHA.,3A.BETA.,7A.BETA.)-OCTAHYDRO-1H-INDOLE-2-CARBONYL-; N~2~-[(2S,3aS,7aS)-1-{(3R)-2-[D-Arginyl-L-arginyl-L-prolyl-(4R)-4-hydroxy-L-prolylglycyl-3-(thiophen-2-yl)-L-alanyl-L-seryl]-1,2,3,4-tetrahydroisoquinoline-3-carbonyl}octahydro-1H-indole-2-carbonyl]-L-arginineSynonyms
Products Containing Icatibant
ICATIBANTO TARBIS 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFGICATIBANTO GP-PHARM 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFGFIRAZYR 30 mg SOLUCION INYECTABLE EN JERINGA PRECARGADAIcatibantHOE 140; ICATIBANTZHEJIANG PEPTITES BIOTECH Co.,Ltd sell "Icatibant"Chengdu Shengnuo Biopharm Co Ltd sell "Icatibant"
